Src‐dependent phosphorylation of μ‐opioid receptor at Tyr336 modulates opiate withdrawal
Opiate withdrawal/negative reinforcement has been implicated as one of the mechanisms for the progression from impulsive to compulsive drug use. Increase in the intracellular cAMP level and protein kinase A (PKA) activities within the neurocircuitry of addiction has been a leading hypothesis for opi...
Gespeichert in:
Veröffentlicht in: | EMBO molecular medicine 2017-11, Vol.9 (11), p.1521-1536 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Opiate withdrawal/negative reinforcement has been implicated as one of the mechanisms for the progression from impulsive to compulsive drug use. Increase in the intracellular cAMP level and protein kinase A (PKA) activities within the neurocircuitry of addiction has been a leading hypothesis for opiate addiction. This increase requires the phosphorylation of μ‐opioid receptor (MOR) at Tyr
336
by Src after prolonged opiate treatment
in vitro
. Here, we report that the Src‐mediated MOR phosphorylation at Tyr
336
is a prerequisite for opiate withdrawal in mice. We observed the recruitment of Src in the vicinity of MOR and an increase in phosphorylated Tyr
336
(pY336) levels during naloxone‐precipitated withdrawal. The intracerebroventricular or stereotaxic injection of a Src inhibitor (AZD0530), or Src shRNA viruses attenuated pY336 levels, and several somatic withdrawal signs. This was also observed in Fyn
−/−
mice. The stereotaxic injection of wild‐type MOR, but not mutant (Y336F) MOR, lentiviruses into the locus coeruleus of MOR
−/−
mice restored somatic withdrawal jumping. Regulating pY336 levels during withdrawal might be a future target for drug development to prevent opiate addictive behaviors.
Synopsis
The μ‐opioid receptor (MOR) non‐canonical signaling pathway involves its phosphorylation at Tyr
336
by Src kinase within the MOR signal complex. The focal event of MOR
Y
336
phosphorylation may be the key for adenylyl cyclase superactivation during the withdrawal/negative stage of opiate addiction.
The phosphorylation levels of MOR
Y
336
and Src
Y416
increased during naloxone‐precipitated withdrawal in wild‐type mice.
The intracerebroventricular or stereotaxic injection of a Src inhibitor (AZD0530), or Src shRNA viruses reduced pMOR
Y
336
and pSrc
Y416
levels, and several somatic withdrawal signs.
Increases of pMOR
Y
336
levels as well as some somatic withdrawal signs after naloxone‐precipitated withdrawal were not observed in Fyn
−/−
mice.
The stereotaxic injection of wild‐type MOR lentiviruses into the locus coeruleus of MOR
−/−
mice restored somatic withdrawal jumping and wet dog shaking.
The stereotaxic injection of the phosphorylation‐deficient mutant (Y336F) MOR, in which the mutation of Tyr
336
to Phe blocks Src‐mediated phosphorylation, attenuated naloxone‐precipitated withdrawal.
Graphical Abstract
The μ‐opioid receptor (MOR) non‐canonical signaling pathway involves its phosphorylation at Tyr
336
by Src kinase within the MOR signal complex. The |
---|---|
ISSN: | 1757-4676 1757-4684 |
DOI: | 10.15252/emmm.201607324 |